Pancreatic Cancer Research

ResearcherCentre Hospitalier de l’Université de MontréalActive in the last 2 years

Gerardo Ferbeyre

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2146-618X; OpenAlex author ID A5067092778. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 5

  1. Effects of Biguanide-PROTACs in Pancreatic Cancer Cells. Co-author DOI 10.3390/molecules29225329↗
  2. Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer. Last author DOI 10.1080/15384101.2023.2278945↗
  3. The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Last author DOI 10.3390/cancers14225597↗
  4. Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. Co-author DOI 10.1038/s41598-021-87993-3↗
  5. Metformin turns off the metabolic switch of pancreatic cancer. Last author DOI 10.18632/aging.102622↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andreea R. Schmitzer · 3 shared papers, 2021–2024 · strength 0.59
  2. Julie Vatté · 1 shared paper, 2024 · strength 0.31
  3. Xavier Deschênes‐Simard · 2 shared papers, 2019–2023 · strength 0.30
  4. Maxime Parisotto · 2 shared papers, 2021–2022 · strength 0.27
  5. Filippos Kottakis · 1 shared paper, 2023 · strength 0.14
  6. MC. Rowell · 1 shared paper, 2023 · strength 0.14
  7. Vikram Deshpande · 1 shared paper, 2023 · strength 0.14
  8. Benjamin Le Calvé · 1 shared paper, 2023 · strength 0.14
  9. Nabeel M. Bardeesy · 1 shared paper, 2023 · strength 0.14
  10. Michaël Pollak · 1 shared paper, 2022 · strength 0.14
  11. Audrey Hébert · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.